Document is current
Any future updates will be listed below
-
Authors
Gerstlauer, Michael
-
Funding
Funding for this research was provided by:
Universitätsklinikum Augsburg
- License Information
-
More Information
Article History
Received: 27 August 2024
Accepted: 17 September 2024
First Online: 4 December 2024
Conflict of interest
: M. Gerstlauer: Clinical studies: Allergopharma, Bencard Allergie, Boehringer, InfectoPharm, Stallergenes-Greer; Consultancy work/lecture fees: AstraZeneca, Aimmune, ALK-Abelló, Allergopharma, Bencard Allergie, Leti Pharma, Meda Pharma, Novartis Pharma, Sanofi, Stallergenes-Greer; Professional associations: AGPAS, GPAU, GPP, DGKJ, EAACI, ERS; Guidelines: NVL bronchial asthma, AWMF: Allergen immunotherapy, Insect venom allergy, Allergy prevention, Bronchial asthma, Severe bronchial asthma in children, Allergic rhinoconjunctivitis.
